Ownership

Dipal Doshi - Insider Trading & Ownership

Entity: Individual
Location: C/O Amicus Therapeutics, 1 Cedar Brook Drive, Cranbury, NJ
Summary: The estimated net worth of Dipal Doshi is at least $5.14M dollars as of February 11, 2025. Dipal Doshi is the CEO, Director of Entrada Therapeutics, Inc. and owns shares of Entrada Therapeutics, Inc. (TRDA) stock worth about $4.93M. Dipal Doshi is the Director of Azenta, Inc. and owns shares of Azenta, Inc. (AZTA) stock worth about $211K.
All Insider Reports: All Insider Reports

Ownership of Dipal Doshi

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
TRDA	Entrada Therapeutics, Inc.	CEO, Director	$4.93M	-$95.2K	-1.9%	Sep 3, 2024
AZTA	Azenta, Inc.	Director	$211K			Feb 7, 2025

Showing 1 to 2 of 2 entries

Insider Transactions Reported by Dipal Doshi:

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership
AZTA	Azenta, Inc.	Common	Award		$211K	52.32	+4.04K	4.04K	2/7/2025	Direct
TRDA	Entrada Therapeutics, Inc.	Common Stock	Tax liability	-0.25%	-$12.5K	15.13	-826	326K	9/5/2024	Direct
TRDA	Entrada Therapeutics, Inc.	Common Stock	Tax liability	-1.43%	-$73.2K	15.42	-4.74K	327K	9/4/2024	Direct
TRDA	Entrada Therapeutics, Inc.	Common Stock	Tax liability	-0.94%	-$50.7K	16.08	-3.15K	331K	9/3/2024	Direct
TRDA	Entrada Therapeutics, Inc.	Common Stock	Sale	-0.48%	-$28.5K	17.81	-1.6K	334K	7/15/2024	Direct
TRDA	Entrada Therapeutics, Inc.	Common Stock	Sale	-0.09%	-$5.4K	18.00	-300	336K	7/12/2024	Direct
TRDA	Entrada Therapeutics, Inc.	Common Stock	Sale	-0.3%	-$16.2K	16.17	-1K	336K	6/13/2024	Direct
TRDA	Entrada Therapeutics, Inc.	Common Stock	Sale	-0.35%	-$18.1K	15.11	-1.2K	337K	5/17/2024	Direct
TRDA	Entrada Therapeutics, Inc.	Common Stock	Sale	-0.53%	-$27K	15.00	-1.8K	339K	5/16/2024	Direct
TRDA	Entrada Therapeutics, Inc.	Common Stock	Tax liability	-1.46%	-$62K	12.28	-5.05K	340K	3/5/2024	Direct
TRDA	Entrada Therapeutics, Inc.	Common Stock	Tax liability	-0.73%	-$33.1K	12.94	-2.56K	345K	3/4/2024	Direct
TRDA	Entrada Therapeutics, Inc.	Common Stock	Award	+43%	$0	0.00	+105K	348K	3/1/2024	Direct
TRDA	Entrada Therapeutics, Inc.	Stock Option (Right to Buy)	Award		$0	0.00	+159K	159K	3/1/2024	Direct
TRDA	Entrada Therapeutics, Inc.	Common Stock	Sale	-0.41%	-$15K	15.00	-1K	243K	2/15/2024	Direct
TRDA	Entrada Therapeutics, Inc.	Common Stock	Sale	-0.41%	-$16K	15.99	-1K	244K	1/16/2024	Direct
TRDA	Entrada Therapeutics, Inc.	Common Stock	Sale	-0.41%	-$15K	15.00	-1K	245K	12/20/2023	Direct
TRDA	Entrada Therapeutics, Inc.	Common Stock	Sale	-0.4%	-$16.2K	16.23	-1K	246K	11/13/2023	Direct
TRDA	Entrada Therapeutics, Inc.	Common Stock	Sale	-0.4%	-$15K	15.00	-1K	247K	10/17/2023	Direct
TRDA	Entrada Therapeutics, Inc.	Common Stock	Sale	-0.4%	-$15K	15.00	-1K	248K	9/13/2023	Direct
TRDA	Entrada Therapeutics, Inc.	Common Stock	Tax liability	-0.57%	-$20.8K	14.46	-1.44K	249K	9/5/2023	Direct
TRDA	Entrada Therapeutics, Inc.	Common Stock	Award	+24.7%	$0	0.00	+49.7K	251K	9/1/2023	Direct
TRDA	Entrada Therapeutics, Inc.	Stock Option (Right to Buy)	Award		$0	0.00	+75.3K	75.3K	9/1/2023	Direct
TRDA	Entrada Therapeutics, Inc.	Common Stock	Sale	-0.49%	-$15.7K	15.67	-1K	201K	8/14/2023	Direct
TRDA	Entrada Therapeutics, Inc.	Common Stock	Sale	-0.98%	-$27.4K	13.71	-2K	202K	4/27/2023	Direct
TRDA	Entrada Therapeutics, Inc.	Common Stock	Sale	-1.01%	-$37.7K	18.01	-2.09K	204K	4/17/2023	Direct
TRDA	Entrada Therapeutics, Inc.	Common Stock	Sale	-0.78%	-$29.4K	14.72	-2K	256K	3/27/2023	Direct
TRDA	Entrada Therapeutics, Inc.	Common Stock	Award	+31.7%	$0	0.00	+49.7K	206K	3/1/2023	Direct
TRDA	Entrada Therapeutics, Inc.	Stock Option (Right to Buy)	Award		$0	0.00	+75.3K	75.3K	3/1/2023	Direct
TRDA	Entrada Therapeutics, Inc.	Common Stock	Sale	-1.22%	-$24K	12.00	-2K	162K	2/28/2023	Direct
TRDA	Entrada Therapeutics, Inc.	Common Stock	Sale	-1.21%	-$24K	12.00	-2K	164K	1/27/2023	Direct
TRDA	Entrada Therapeutics, Inc.	Common Stock	Sale	-1.43%	-$36.2K	15.02	-2.41K	166K	1/9/2023	Direct
TRDA	Entrada Therapeutics, Inc.	Common Stock	Sale	-0.24%	-$6.01K	15.01	-400	168K	12/29/2022	Direct
TRDA	Entrada Therapeutics, Inc.	Common Stock	Sale	-2.61%	-$67.9K	15.01	-4.52K	169K	12/28/2022	Direct
TRDA	Entrada Therapeutics, Inc.	Common Stock	Sale	-5.29%	-$145K	15.02	-9.67K	173K	12/27/2022	Direct
TRDA	Entrada Therapeutics, Inc.	Common Stock	Sale	-1.08%	-$27.8K	13.91	-2K	183K	11/28/2022	Direct
TRDA	Entrada Therapeutics, Inc.	Common Stock	Sale	-1.07%	-$43.3K	21.66	-2K	185K	10/27/2022	Direct
TRDA	Entrada Therapeutics, Inc.	Common Stock	Sale	-6.06%	-$249K	20.66	-12.1K	187K	10/25/2022	Direct
TRDA	Entrada Therapeutics, Inc.	Common Stock	Sale	-1.16%	-$45.2K	19.30	-2.34K	199K	10/24/2022	Direct
TRDA	Entrada Therapeutics, Inc.	Common Stock	Sale	-1.37%	-$50.9K	18.28	-2.79K	201K	10/21/2022	Direct
TRDA	Entrada Therapeutics, Inc.	Common Stock	Sale	-0.4%	-$14.6K	18.01	-811	204K	10/20/2022	Direct
TRDA	Entrada Therapeutics, Inc.	Common Stock	Sale	-1.48%	-$47K	15.23	-3.09K	205K	9/28/2022	Direct
TRDA	Entrada Therapeutics, Inc.	Common Stock	Sale	-2.08%	-$67.2K	15.21	-4.42K	208K	9/27/2022	Direct
TRDA	Entrada Therapeutics, Inc.	Common Stock	Sale	-1.43%	-$47.2K	15.32	-3.08K	212K	9/26/2022	Direct
TRDA	Entrada Therapeutics, Inc.	Common Stock	Sale	-0.47%	-$15.4K	15.07	-1.02K	215K	9/23/2022	Direct
TRDA	Entrada Therapeutics, Inc.	Common Stock	Sale	-1.55%	-$51.4K	15.12	-3.4K	216K	9/21/2022	Direct
TRDA	Entrada Therapeutics, Inc.	Common Stock	Sale	-0.09%	-$3.01K	15.04	-200	220K	9/15/2022	Direct
TRDA	Entrada Therapeutics, Inc.	Common Stock	Sale	-0.31%	-$10.4K	15.07	-688	220K	9/9/2022	Direct
TRDA	Entrada Therapeutics, Inc.	Common Stock	Sale	-0.5%	-$16.7K	15.16	-1.1K	221K	9/8/2022	Direct
TRDA	Entrada Therapeutics, Inc.	Common Stock	Award	+7.32%	$0	0.00	+15.1K	222K	9/1/2022	Direct
TRDA	Entrada Therapeutics, Inc.	Common Stock	Sale	-0.08%	-$2.05K	12.00	-171	207K	8/31/2022	Direct

Previous1 2Next

Showing 1 to 50 of 60 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.